Medicare Enrolled
Dr. Laura Birnbaum, M.D.
Family Medicine · Giddings, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Birnbaum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Birnbaum?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Birnbaum
Dr. Laura Birnbaum is a family medicine specialist in Giddings, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Birnbaum performed 2,397 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Birnbaum received a total of $6,437 from 36 pharmaceutical and/or device companies across 393 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Birnbaum is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in TX
$6,437 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,397
Medicare services
Top 11% in TX for family medicine
Not available
Unique patients (not deduplicated)
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
536 | $51 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
303 | $78 | $160 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
275 | $10 | $40 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
233 | $124 | $230 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
198 | $6 | $35 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
109 | $15 | $45 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
107 | $22 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
107 | $29 | $30 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
94 | $36 | $75 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
80 | $2 | $15 |
| Annual depression screening | 69 | $18 | $60 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
61 | $8 | $30 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
52 | $4 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $124 | $230 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
41 | $16 | $59 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
23 | $3 | $25 |
| COVID-19 viral test, non-CDC A laboratory test to detect the SARS-CoV-2 virus (COVID-19) using any technique and targeting multiple types or subtypes. This specific code is for tests performed by laboratories that are not the CDC. |
18 | $50 | $62 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
14 | $4 | $50 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
14 | $5 | $35 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
14 | $158 | $210 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,437
Total received (2018-2024)
Avg $920/year across 7 years
Top 9% in TX for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
393
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$956
2023
$685
2022
$825
2021
$993
2020
$915
2019
$1,137
2018
$928
Payments by company (2024)
Corcept Therapeutics
$208
Novo Nordisk Inc
$208
Abbott Laboratories
$149
Amgen Inc.
$107
PFIZER INC.
$84
IDORSIA PHARMACEUTICALS US INC
$38
ABBVIE INC.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
AstraZeneca Pharmaceuticals LP
$22
Antares Pharma, Inc.
$18
E.R. Squibb & Sons, L.L.C.
$16
Exact Sciences Corporation
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
Tolmar, Inc.
$15
Top 3 companies account for 59.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,075
Amgen Inc.
$518
AstraZeneca Pharmaceuticals LP
$488
Lilly USA, LLC
$413
Takeda Pharmaceuticals U.S.A., Inc.
$399
Corcept Therapeutics
$208
GlaxoSmithKline, LLC.
$182
AbbVie Inc.
$176
PFIZER INC.
$169
Abbott Laboratories
$166
ABBVIE INC.
$158
Astellas Pharma US Inc
$156
Boehringer Ingelheim Pharmaceuticals, Inc.
$146
Mylan Specialty L.P.
$116
Allergan, Inc.
$112
IDORSIA PHARMACEUTICALS US INC
$101
Merck Sharp & Dohme Corporation
$96
Eisai Inc.
$83
Bayer HealthCare Pharmaceuticals Inc.
$79
SANOFI-AVENTIS U.S. LLC
$73
Janssen Pharmaceuticals, Inc
$67
Allergan Inc.
$61
Antares Pharma, Inc.
$51
Amarin Pharma Inc.
$49
Novartis Pharmaceuticals Corporation
$44
Merck Sharp & Dohme LLC
$41
Exact Sciences Corporation
$33
Genentech USA, Inc.
$30
Hologic, LLC
$22
Supernus Pharmaceuticals, Inc.
$22
GENZYME CORPORATION
$20
Axsome Therapeutics, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$16
Biohaven Pharmaceuticals, Inc.
$16
Tolmar, Inc.
$15
Regeneron Healthcare Solutions, Inc.
$13
Top 3 companies account for 47.9% of all-time payments
Associated products mentioned in payments ›
AREXVY · Aimovig · Aptima Combo 2 · Auvelity · BASAGLAR · BELSOMRA · BEXSERO · BREO · BYDUREON · BYSTOLIC · CHANTIX · Cologuard Collection Kit · DUPIXENT · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL 9 · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LINZESS · MOUNJARO · MYRBETRIQ · Myrbetriq · NOCDURNA · NURTEC ODT · OFEV · Otezla · Ozempic · PAXLOVID · PRALUENT ALIROCUMAB INJECTION · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Prolia · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SYNTHROID · Saxenda · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · UBRELVY · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xofluza · Xultophy 100/3.6 · YUPELRI · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
29
County median income
$66,000
Nearest hospital to ZIP centroid (approximate)
ASCENSION SETON SMITHVILLE
17.6 mi
17.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Birnbaum is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Birnbaum experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Birnbaum performed 536 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Birnbaum receive payments from pharmaceutical companies?
Yes. Dr. Birnbaum received a total of $6,437 from 36 companies across 393 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Birnbaum's costs compare to other family medicine physicians in Giddings?
Dr. Birnbaum's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Birnbaum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Giddings
Browse family medicine physicians in Giddings ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology